Market Expansion:
The client base appears to have grown from 800+ hospitals in 2021 to more than 1,000 by the October 2025 acquisition, indicating broader market reach. The buyer also stated the deal would expand its total addressable market by more than 15%.
Product Line Growth:
Offerings broadened through acquisitions of Artifact Health and ChartWise and launches such as AwareUM and pre-bill capabilities. This reflects expansion from core CDI into utilization management and adjacent mid–revenue-cycle workflows.
Investor Backing & Capital Strength:
The company reached a valuation of about $1 billion in 2021 and was acquired for approximately $1.25 billion in 2025. The acquirer characterized the business as a highly recurring subscription model expected to be accretive to its financial profile.
